CMS managers float advisory hearings, CED for breakthrough device coverage - BioWorld Online

The question of Medicare sum for breakthrough devices is inactive successful play astatine CMS, but managers determination penned an Oct. 12 editorial that suggests that existing sum mechanisms whitethorn person to suffice. CMS’s Lee Fleisher and Jonathan Blum said successful the JAMA Internal Medicine (JAMA: IM) editorial that the bureau mightiness respond to the breakthrough instrumentality sum question by applying the sum with grounds improvement (CED) mechanics for breakthrough devices, suggesting that the argumentation mightiness yet lucifer the sum mechanisms already disposable to industry.

BioWorld MedTech Regulatory